Skip Navigation



Family Practice Advance Access published online on January 20, 2006
Family Practice, doi:10.1093/fampra/cmi107
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/2/203    most recent
cmi107v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by McNulty, C.
Right arrow Articles by Delaney, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNulty, C.
Right arrow Articles by Delaney, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press. All rights reserved.
Received April 27, 2005
Accepted December 9, 2005

Article

Helicobacter pylori test & treat strategy for dyspepsia: a qualitative study exploring the barriers and how to overcome them

Cliodna McNulty 1, Elaine Freeman 2, and Brendan Delaney 3

1 Health Protection Agency Primary Care Unit, Gloucester, UK
2 Gloucestershire Research & Development Support Unit, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
3 University of Birmingham, Department of Primary Care and General Practice, Birmingham, UK


  Abstract

Background. The National Institute of Clinical Excellence (NICE) has issued guidance that recommends that all dyspeptic patients without alarm symptoms, irrespective of age, that relapse after one month's proton pump inhibitor, should be offered test and treat for Helicobacter pylori.

Objective. To explore the views of primary care about introducing the helicobacter test and treat NICE dyspepsia guidance.

Methods. In 15 urban and rural general practices in Central England, primary health care staff involved in the management of dyspepsia took part in qualitative focus groups to discuss the draft NICE guidance and how it might be implemented.

Results. Practices expressed concern that test and treat may not be cost-effective in younger patients and that they may miss malignancy, in older patients and in patients who relapse after triple treatment, without a further helicobacter test or endoscopy. The greatest practical barriers to test and treat were the considerable impact on nurses' and doctors' time to explain, undertake tests and report results to patients, and practice budgets from urea breath test and triple treatment costs. Staff preferred stool tests to breath tests, as they impacted less on practice budget and time. GPs did not favour prescribing the three components of the triple treatment separately.

Conclusions. GPs will need reassurance that test and treat will not lead to missed malignancies. The financial costs and staffing implications of NICE dyspepsia guidance will need to be discussed locally by Primary Care Trusts, microbiology laboratories, gastroenterologists and pharmacy advisors and implemented with local guidance, increased communication and education.

Keywords: Diagnostic tests; Helicobacter pylori; implementation; NICE guidance; qualitative.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.